跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-315
首页
药物
A-315
A-315
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITION FOR UV ABSORPTION AND METHOD FOR MANUFACTURING SAME
申请人: FUJI PIGMENT
优先权: 2022
CN
EP
US
WO
4 件公开
ADVANTAGEOUS HUMAN DOSAGE REGIMENS FOR ADMINISTRATION OF INX-315
申请人: INCYCLIX BIO LLC
优先权: 2023
CN
EP
US
WO
4 件公开
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
申请人: PLETNEV ALEXANDER G
优先权: 2010
US
4 件公开
Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof
申请人: DRACOPHARMA INC
优先权: 2010
US
4 件公开
Peptide compositions and methods for inhibiting herpesvirus infection
申请人: MELNIK LILIA I
优先权: 2010
US
4 件公开
PESTICIDAL ACTX PEPTIDE VARIANTS
申请人: VESTARON CORP
优先权: 2022
EP
US
WO
3 件公开
VITAMIN D PROMOTING SUNSCREEN
申请人: ARMSTRONG ERNEST T
优先权: 2009
EP
US
3 件公开
Neutralising antibody against dengue for use in a method of prevention and/or treatment of zika infection
申请人: IMP INNOVATIONS LTD
优先权: 2016
US
WO
3 件公开
Combination cancer therapy with bis(thiohydrazide) amide compounds
申请人: SYNTA PHARMACEUTICALS CORP
优先权: 2006
US
3 件公开
Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants
申请人: EVOGENE LTD
优先权: 2017
US
3 件公开
第 1 / 8 页
上一页
下一页
药物
反馈